You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥現代(600420.SH):全資孫公司獲得化學原料藥上市申請批准通知書
格隆匯 04-08 17:14

格隆匯4月8日丨國藥現代(600420.SH)公佈,公司全資孫公司江蘇威奇達藥業有限公司(稱國藥江蘇威奇達)收到國家藥品監督管理局核准簽發的《化學原料藥上市申請批准通知書》,批准原料藥枸櫞酸託法替布上市申請,託法替布是一種酪氨酸激酶(JAKs)抑制劑,主要適用於治療對氨甲喋呤反應不佳或不能耐受的中度至重度活動性類風濕性關節炎成年患者。相關製劑產品枸櫞酸託法替布片可緩解類風濕性關節炎引起的多種症狀,如:關節疼痛、關節變形等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account